Progenika Gives Grifols Rights to Distribute Bloodchip

The chips are anticipated to generate revenues of between $62 million and $123 million during the next five years, according to Progenika.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.